Cor Vasa 2018, 60(1):e35-e41 | DOI: 10.1016/j.crvasa.2017.10.001

Endovascular management of patients with peripheral vascular disease with cardiovascular multi-morbidity

Ahmed Eid, Sigrid Nikol*
Department of Clinical and Interventional Angiology, St. Georg Hospital, Hamburg, Germany

Polyvascular presentation among patients with peripheral artery disease is common. The cardiovascular burden among those patients highlights the need of minimally invasive therapeutic techniques. Advances in endovascular technology and skills over the last decades offer an alternative to open surgery. This review discusses the cardiovascular morbidity in patients with peripheral artery disease and currently utilized endovascular management.

Keywords: Cardiovascular morbidity; Endovascular therapy; Intervention; Peripheral vascular disease

Received: August 31, 2017; Revised: October 1, 2017; Accepted: October 3, 2017; Published: February 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Eid A, Nikol S. Endovascular management of patients with peripheral vascular disease with cardiovascular multi-morbidity. Cor Vasa. 2018;60(1):e35-41. doi: 10.1016/j.crvasa.2017.10.001.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. F.G. Fowkes, D. Rudan, I. Rudan, et al., Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis, Lancet 382 (2013) 1329-1340. Go to original source... Go to PubMed...
    2. S. Subherwal, D.L. Bhatt, S. Li, et al., Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction, Circulation: Cardiovascular Quality and Outcomes 5 (2012) 541-549. Go to original source... Go to PubMed...
    3. T.W. Rooke, A.T. Hirsch, S. Misra, et al., 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline), Circulation 124 (2011) 2020-2045. Go to original source... Go to PubMed...
    4. G.C. Leng, A.J. Lee, F.G. Fowkes, et al., Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population, International Journal of Epidemiology 25 (1996) 1172-1181. Go to original source... Go to PubMed...
    5. L. Norgren, W.R. Hiatt, J.A. Dormandy, et al., Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), Journal of Vascular Surgery 45 (2007) S5-S67. Go to original source... Go to PubMed...
    6. M.H. Criqui, R.D. Langer, A. Fronek, et al., Mortality over a period of 10 years in patients with peripheral arterial disease, New England Journal of Medicine 326 (1992) 381-386. Go to original source... Go to PubMed...
    7. G.M. Ansel, A.B. Lumsden, Evolving modalities for femoropopliteal interventions, Journal of Endovascular Therapy 16 (2009) 82-97. Go to original source... Go to PubMed...
    8. J.H. Rogers, J.R. Laird, Overview of new technologies for lower extremity revascularization, Circulation 116 (2007) 2072-2085. Go to original source... Go to PubMed...
    9. J. Caro, K. Migliaccio-Walle, K.J. Ishak, I. Proskorovsky, The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database, BMC Cardiovascular Disorders 5 (2005) 14. Go to original source... Go to PubMed...
    10. G.M. Welten, O. Schouten, S.E. Hoeks, et al., Long-term prognosis of patients with peripheral arterial disease, Journal of the American College of Cardiology 51 (2008) 1588-1596. Go to original source... Go to PubMed...
    11. P. Poredoš, B. Jug, The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients, Angiology 58 (2007) 309-315. Go to original source... Go to PubMed...
    12. R.S. Dieter, J. Tomasson, T. Gudjonsson, et al., Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease, Vascular Medicine 8 (2003) 233-236. Go to original source... Go to PubMed...
    13. B. Atmer, T. Jogestrand, J. Laska, F. Lund, Peripheral artery disease in patients with coronary artery disease, International Angiology 14 (1995) 89-93.
    14. M. Tendera, V. Aboyans, M.L. Bartelink, et al., ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC), European Heart Journal 32 (2011) 2851-2906. Go to original source...
    15. J. Ness, W.S. Aronow, Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice, Journal of the American Geriatrics Society 47 (1999) 1255-1256. Go to original source... Go to PubMed...
    16. W.S. Aronow, C. Ahn, Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women ≥62 years of age, American Journal of Cardiology 74 (1994) 64-65. Go to original source... Go to PubMed...
    17. P.G. Steg, D.L. Bhatt, P.W. Wilson, et al., REACH Registry Investigators, One-year cardiovascular event rates in outpatients with atherothrombosis, Journal of the American Medical Association 297 (2007) 1197-1206. Go to original source... Go to PubMed...
    18. W.S. Jones, R. Clare, S.J. Ellis, et al., Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION), American Journal of Cardiology 108 (2011) 380-384. Go to original source... Go to PubMed...
    19. S.C. Inglis, J.V. McMurray, M. Boehm, et al., Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA), European Journal of Heart Failure 12 (2010) 698-705. Go to original source... Go to PubMed...
    20. B. Ahmed, H. Al-Khaffaf, Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: a meta-analysis, European Journal of Vascular and Endovascular Surgery 37 (2009) 262-271. Go to original source... Go to PubMed...
    21. H. Fan, X. Hu, W. Yu, et al., Low ankle-brachial index and risk of stroke, Atherosclerosis 229 (2013) 317-323. Go to original source... Go to PubMed...
    22. C. Weimar, M. Goertler, J. Röther, et al., SCALA Study Group, Predictive value of the Essen Stroke Risk Score and Ankle Brachial Index in acute ischaemic stroke patients from 85 German stroke units, Journal of Neurology, Neurosurgery, and Psychiatry 79 (2008) 1339-1343. Go to original source... Go to PubMed...
    23. R. Topakian, S. Nanz, B. Rohrbacher, et al., OECROSS Study Group, High prevalence of peripheral arterial disease in patients with acute ischaemic stroke, Cerebrovascular Diseases 29 (2010) 248-254. Go to original source... Go to PubMed...
    24. M.J. Alberts, D.L. Bhatt, J.L. Mas, et al., Reduction of Atherothrombosis for Continued Health Registry Investigators, Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry, European Heart Journal 30 (2009) 2318-2326. Go to original source... Go to PubMed...
    25. W.B. Kannel, J.J. Skinner, M.J. Schwartz, D. Shurtleff, Intermittent claudication: incidence in the Framingham study, Circulation 41 (1970) 875-883. Go to original source... Go to PubMed...
    26. S.C. Muluk, V.S. Muluk, M.E. Kelley, et al., Outcome events in patients with claudication: a 15-year study in 2777 patients, Journal of Vascular Surgery 33 (2001) 251-258. Go to original source... Go to PubMed...
    27. R. Aquino, C. Johannides, M. Makaroun, et al., Natural history of claudication: long-term serial follow-up study of 1244 claudicants, Journal of Vascular Surgery 34 (2001) 962-970. Go to original source... Go to PubMed...
    28. T. Zeller, Current state of endovascular treatment of femoro-popliteal artery disease, Vascular Medicine 12 (2007) 223-234. Go to original source... Go to PubMed...
    29. A.W. Bradbury, D.J. Adam, J. Bell, et al., Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial, Health Technology Assessment 14 (2010) 1-252. Go to original source... Go to PubMed...
    30. P.K. Moulik, R. Mtonga, G.V. Gill, Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology, Diabetes Care 26 (2003) 491-494. Go to original source... Go to PubMed...
    31. D.G. Armstrong, J. Wrobel, J.M. Robbins, Guest Editorial: are diabetes-related wounds and amputations worse than cancer?, International Wound Journal 4 (2007) 286-287. Go to original source... Go to PubMed...
    32. Cancer Registration Statistics, England - Office for National Statistics (ONS), 2004.
    33. K.W. Chiu, R.S. Davies, P.G. Nightingale, et al., Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease, European Journal of Vascular and Endovascular Surgery 39 (2010) 460-471. Go to original source... Go to PubMed...
    34. J. Nordanstig, J. Gelin, M. Hensäter, et al., Walking performance and health-related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication - a prospective randomised trial, European Journal of Vascular and Endovascular Surgery 42 (2011) 220-227. Go to original source... Go to PubMed...
    35. R. Bedenis, M. Stewart, M. Cleanthis, et al., Cilostazol for intermittent claudication, Cochrane Database of Systematic Reviews (10) (2014) CD003748. Go to original source...
    36. S.D. Kristensen, A. Knuuti, A. Saraste, et al., 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA), European Heart Journal 35 (2014) 2383-2431. Go to original source... Go to PubMed...
    37. G.A. Antoniou, N. Chalmers, G.S. Georgiadis, et al., A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease, Journal of Vascular Surgery 57 (2013) 242-253. Go to original source... Go to PubMed...
    38. V. Jongkind, G.J.M. Akkersdijk, K.K. Yeung, W. Wisselink, A systematic review of endovascular treatment of extensive aortoiliac occlusive disease, Journal of Vascular Surgery 52 (2010) 1376-1383. Go to original source... Go to PubMed...
    39. W. Ye, C.W. Liu, J.B. Ricco, et al., Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions, Journal of Vascular Surgery 53 (2011) 1728-1737. Go to original source... Go to PubMed...
    40. H.H. Dosluoglu, G.S. Cherr, P. Lall, et al., Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease, Journal of Vascular Surgery 48 (2008) 1166-1174. Go to original source... Go to PubMed...
    41. K. McQuade, D. Gable, G. Pearl, et al., Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versusprosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease, Journal of Vascular Surgery 52 (2010) 584-590, discussion 590-591, 591.e1-7. Go to original source... Go to PubMed...
    42. J.R. Laird, B.T. Katzen, D. Scheinert, et al., Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial, Circulation. Cardiovascular Interventions 2010;3:267-276. Go to original source... Go to PubMed...
    43. J.R. Laird, B.T. Katzen, D. Scheinert, et al., Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the resilient randomized trial, Journal of Endovascular Therapy 19 (2012) 1-9. Go to original source... Go to PubMed...
    44. A. Kashyap, K.P. Anand, S. Kashyap, Balloon angioplasty or nitinol stents for peripheral-artery disease, New England Journal of Medicine 355 (2006) 521-524. Go to original source... Go to PubMed...
    45. M. Schillinger, S. Sabeti, P. Dick, et al., Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting, Circulation 115 (2007) 2745-2749. Go to original source... Go to PubMed...
    46. H. Krankenberg, M. Schlüter, H.J. Steinkamp, et al., Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST), Circulation 116 (2007) 285-292. Go to original source... Go to PubMed...
    47. M. Werk, S. Langner, B. Reinkensmeier, et al., Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial, Circulation 118 (2008) 1358-1365. Go to original source... Go to PubMed...
    48. G. Tepe, T. Zeller, T. Albrecht, et al., Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg, New England Journal of Medicine 358 (2008) 689-699. Go to original source... Go to PubMed...
    49. F. Fanelli, A. Cannavale, E. Boatta, et al., Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial, Journal of Endovascular Therapy 19 (2012) 571-580. Go to original source... Go to PubMed...
    50. S. Cassese, R.A. Byme, I. Otte, et al., Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials, Circulation: Cardiovascular Interventions 5 (2012) 582-589. Go to original source... Go to PubMed...
    51. M.D. Dake, G.M. Ansel, M.R. Jaff, et al., Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month zilver PTX randomized study results, Circulation: Cardiovascular Interventions 4 (2011) 495-504. Go to original source... Go to PubMed...
    52. M.D. Dake, G.M. Ansel, M.R. Jaff, et al., Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery clinical perspective: 5-year results of the zilver PTX randomized trial, Circulation 133 (2016) 1472-1483. Go to original source... Go to PubMed...
    53. S.H. Duda, M. Bosiers, J. Lammer, et al., Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial, Journal of Endovascular Therapy 13 (2006) 701-710. Go to original source... Go to PubMed...
    54. M.I. Söderström, E.M. Arvela, M. Korhonen, et al., Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a propensity score analysis, Annals of Surgery 252 (2010) 765-773. Go to original source... Go to PubMed...
    55. F. Liistro, I. Porto, P. Angioli, et al., Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK) clinical perspective: a randomized trial in diabetic patients with critical limb ischemia, Circulation 128 (2013) 615-621. Go to original source... Go to PubMed...
    56. T. Zeller, I. Baumgartner, D. Scheinert, et al., Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial, Journal of the American College of Cardiology 64 (2014) 1568-1576. Go to original source... Go to PubMed...
    57. T. Zeller, U. Beschorner, E. Pilger, et al., Paclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II randomized trial (BIOTRONIK'S-first in man study of the Passeo-18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries), JACC: Cardiovascular Interventions 8 (2015) 1614-1622. Go to original source... Go to PubMed...
    58. A. Rastan, K. Brechtel, H. Krankenberg, et al., Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents, Journal of the American College of Cardiology 60 (2012) 587-591. Go to original source... Go to PubMed...
    59. G.A. Antoniou, N. Chalmers, K. Kanesalingham, et al., Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents, Journal of Endovascular Therapy 20 (2013) 131-144. Go to original source... Go to PubMed...
    60. M. Fusaro, S. Cassese, G. Ndrepepa, et al., Drug-eluting stents for revascularization of infrapopliteal arteries, JACC: Cardiovascular Interventions 6 (2013) 1284-1293. Go to original source... Go to PubMed...
    61. K. Ouriel, C.K. Shortell, J.A. DeWeese, et al., A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia, Journal of Vascular Surgery 19 (1994) 1021-1030. Go to original source... Go to PubMed...
    62. K. Ouriel, F.J. Veith, A.A. Sasahara, A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs, New England Journal of Medicine 338 (1998) 1105-1111. Go to original source... Go to PubMed...
    63. F.A. Weaver, A.J. Comerota, M. Youngblood, et al., Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial, Journal of Vascular Surgery 24 (1996) 513-523. Go to original source... Go to PubMed...
    64. C. Wissgott, P. Kamusella, A. Richter, et al., Treatment of acute femoropopliteal bypass graft occlusion: comparison of mechanical rotational thrombectomy with ultrasound-enhanced lysis, ROFO 180 (2008) 547-552. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes